Equillium Inc (EQ)
1.46
-0.03
(-2.01%)
USD |
NASDAQ |
May 01, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Equillium Profit Margin (Quarterly): -25.43% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -25.43% |
| September 30, 2023 | -41.83% |
| June 30, 2023 | -36.64% |
| Date | Value |
|---|---|
| March 31, 2023 | -44.37% |
| December 31, 2022 | 17.60% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-44.37%
Minimum
Mar 2023
17.60%
Maximum
Dec 2022
-26.13%
Average
-36.64%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Janux Therapeutics Inc | -477.8% |
| Retractable Technologies Inc | -0.51% |
| Mersana Therapeutics Inc | -182.6% |
| Spero Therapeutics Inc | 71.27% |
| Vera Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.44% |
| Return on Assets | -21.18% |
| Return on Invested Capital | -44.04% |
| Operating Margin (Quarterly) | -34.74% |
| Return on Net Operating Assets | -210.9% |